Clinical Trials Register

Trials with a EudraCT protocol (2,613)
Paediatric studies in scope of Art45 of the Paediatric Regulation (2)

2,613 result(s) found for: Lung diseases. Displaying page 1 of 131.

EudraCT Number: 2008-004771-22

Sponsor Protocol Number: Vs.12.11-07-2008

Start Date*: 2008-09-03

Sponsor Name:Rigshospitalet, Kardiologisk afd

Full Title: Prospective randomised dubbleblind placebocontrolled trial of calcium antagonist to prevent calcineurin induced nephropathy in lung transplanted patients

Medical condition: kidney damage in ciclosporin treated lung transplant patients.

Disease:	Version	SOC Term	Classification Code	Term	Level
	14.1	10038359 - Renal and urinary disorders	10029155	Nephropathy toxic	PT
	14.1	10042613 - Surgical and medical procedures	10056409	Heart and lung transplant	PT
	14.1	10042613 - Surgical and medical procedures	10025127	Lung transplant	PT

Population Age: Adults

Gender: Male, Female

Trial protocol: DK (Completed)

Trial results: (No results available)

EudraCT Number: 2021-005729-25

Sponsor Protocol Number: LUNGVAC

Start Date*: 2022-05-09

Sponsor Name:Vestre Viken Health Trust

Full Title: A Randomized Phase II, Open-label, Multicenter Study Investigating Efficacy and Safety of anti-PD-1/PD-L1 treatment +/- UV1 vaccination as first line treatment in patients with inoperable advanced ...

Medical condition: Inoperable advanced or metastatic non-small cell lung cancer (NSCLC)

Disease:	Version	SOC Term	Classification Code	Term	Level
	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10061873	Non-small cell lung cancer	PT
	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10029515	Non-small cell lung cancer recurrent	PT
	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10029519	Non-small cell lung cancer stage III	PT
	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10029520	Non-small cell lung cancer stage IIIA	PT
	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10029521	Non-small cell lung cancer stage IIIB	PT
	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10029522	Non-small cell lung cancer stage IV	PT
	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10050017	Lung cancer metastatic	PT
	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10059515	Non-small cell lung cancer metastatic	PT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10025044	Lung cancer	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: NO (Trial now transitioned)

Trial results: (No results available)

EudraCT Number: 2011-000130-11

Sponsor Protocol Number: EryDexFCTx1.0

Start Date*: 2011-07-25

Sponsor Name:AZIENDA UNIVERSITARIA POLICLINICO UMBERTO I DI ROMA

Full Title: Clinical trials in rare diseases: therapeutic alternative to the use of oral corticosteroids in patients with cystic fibrosis underwent double lung transplantation.

Medical condition: Double lung transplantation in patients with Cystic Fibrosis

Disease:	Version	SOC Term	Classification Code	Term	Level
	14.1	10010331 - Congenital, familial and genetic disorders	10011763	Cystic fibrosis lung	PT
	14.1	10042613 - Surgical and medical procedures	10025127	Lung transplant	PT

Population Age: Adolescents, Under 18, Adults

Gender: Male, Female

Trial protocol: IT (Ongoing)

Trial results: (No results available)

EudraCT Number: 2016-003790-18

Sponsor Protocol Number: N16HYP

Start Date*: 2017-04-28

Sponsor Name:The Netherlands Cancer Institute

Full Title: Feasibility trial on combination of platinum doublets and hypofractionated radiotherapy for locally-advanced stage and / or inoperable non-small cell lung carcinoma

Medical condition: Locally advanced non-small cell lung carcinoma stage III or inoperable stage II

Disease:	Version	SOC Term	Classification Code	Term	Level
	19.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10025044	Lung cancer	LLT
	19.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10025053	Lung cancer non-small cell stage IIIA	LLT
	19.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10025054	Lung cancer non-small cell stage IIIB	LLT
	19.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10025051	Lung cancer non-small cell stage II	LLT
	19.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10025052	Lung cancer non-small cell stage III	LLT
	19.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10001252	Adenosquamous cell lung cancer stage IIIA	LLT
	19.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10001253	Adenosquamous cell lung cancer stage IIIB	LLT
	19.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10025060	Lung cancer stage II	LLT
	19.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10025061	Lung cancer stage III	LLT
	19.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10001255	Adenosquamous cell lung cancer stage unspecified	LLT
	19.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10001246	Adenosquamous cell lung cancer NOS	LLT
	19.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10061873	Non-small cell lung cancer	PT
	19.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10029518	Non-small cell lung cancer stage II	PT
	19.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10029519	Non-small cell lung cancer stage III	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: NL (Ongoing)

Trial results: (No results available)

EudraCT Number: 2018-001005-85

Sponsor Protocol Number: ATX-NS-001

Start Date*: 2021-07-06

Sponsor Name:Achilles Therapeutics UK Limited

Full Title: An open label, multi-centre, phase I/IIa study evaluating the safety and clinical activity of neoantigen reactive T cells in patients with advanced non-small cell lung cancer.

Medical condition: Non-small cell lung cancer

Disease:	Version	SOC Term	Classification Code	Term	Level
	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10001245	Adenosquamous cell lung cancer	PT
	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10001247	Adenosquamous cell lung cancer recurrent	PT
	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10001251	Adenosquamous cell lung cancer stage III	PT
	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10001254	Adenosquamous cell lung cancer stage IV	PT
	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10023775	Large cell lung cancer recurrent	PT
	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10023779	Large cell lung cancer stage III	PT
	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10023780	Large cell lung cancer stage IV	PT
	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10029515	Non-small cell lung cancer recurrent	PT
	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10029519	Non-small cell lung cancer stage III	PT
	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10029520	Non-small cell lung cancer stage IIIA	PT
	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10029521	Non-small cell lung cancer stage IIIB	PT
	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10029522	Non-small cell lung cancer stage IV	PT
	27.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10050017	Lung cancer metastatic	PT
	27.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10059515	Non-small cell lung cancer metastatic	PT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10025044	Lung cancer	LLT
	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10001246	Adenosquamous cell lung cancer NOS	LLT
	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10029514	Non-small cell lung cancer NOS	LLT
	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10001253	Adenosquamous cell lung cancer stage IIIB	LLT
	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10023774	Large cell lung cancer	PT
	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10001252	Adenosquamous cell lung cancer stage IIIA	LLT
	20.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10025048	Lung cancer non-small cell recurrent	LLT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10025052	Lung cancer non-small cell stage III	LLT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10025054	Lung cancer non-small cell stage IIIB	LLT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10025053	Lung cancer non-small cell stage IIIA	LLT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10025055	Lung cancer non-small cell stage IV	LLT
	27.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10066490	Progression of non-small cell lung cancer	LLT
	27.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10069730	Large cell lung cancer metastatic	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Trial now transitioned) FR (Trial now transitioned) NL (Completed)

Trial results: (No results available)

EudraCT Number: 2017-000659-23

Sponsor Protocol Number: 220365-2017

Start Date*: 2017-10-11

Sponsor Name:Aarhus University Hospital

Full Title: A Safety and feasibility study of standard dosing day 1 carboplatin AUC 5 every 3rd weeks with daily Navelbine® 20/30mg (oral) during 4 cycles (12 weeks) for the treatment of advanced NSCLC; A feas...

Medical condition: Patients with metastatic or locally advanced Non-small-cell lung cancer (NSCLC)

Disease:	Version	SOC Term	Classification Code	Term	Level
	20.0	100000015855	10025044	Lung cancer	LLT
	20.0	100000015841	10025055	Lung cancer non-small cell stage IV	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DK (Completed)

Trial results: View results

EudraCT Number: 2020-002773-10

Sponsor Protocol Number: IRFMN-LUNG-8287

Start Date*: 2022-03-14

Sponsor Name:IRCCS- ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI

Full Title: A phase III prevention trial of canakinumab in subjects at high risk for lung cancer

Medical condition: Subjects at high risk for lung cancer

Disease:	Version	SOC Term	Classification Code	Term	Level
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10058467	Lung neoplasm malignant	PT
	20.0	100000004865	10078411	Primary prevention	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: IT (Prematurely Ended)

Trial results: (No results available)

EudraCT Number: 2020-003512-27

Sponsor Protocol Number: AIO-YMO/TRK-0120

Start Date*: 2021-12-08

Sponsor Name:AIO-Studien-gGmbH

Full Title: Radiation during Osimertinib Treatment: a Safety and Efficacy Cohort Study

Medical condition: Patients with EGFR-mutation positive NSCLC The target population will comprise 3 parallel cohorts, for each of which a minimum of 10 subjects is planned to be enrolled: 1. Irradiation of bone, sol...

Disease:	Version	SOC Term	Classification Code	Term	Level
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10025064	Lung carcinoma	LLT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10007096	Cancer of lung	LLT
	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10061873	Non-small cell lung cancer	PT
	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10029522	Non-small cell lung cancer stage IV	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Trial now transitioned)

Trial results: (No results available)

EudraCT Number: 2014-005614-29

Sponsor Protocol Number: CC-486-NSCL-001

Start Date*: 2015-11-19

Sponsor Name:Celgene Corporation

Full Title: A Phase 2 multicenter, randomized, placebo controlled, double-blind study to assess the safety and efficacy of CC-486 (oral azacitidine) in combination with pembrolizumab (MK-3475) versus pembroliz...

Medical condition: Second-line treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC).

Disease:	Version	SOC Term	Classification Code	Term	Level
	18.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10029522	Non-small cell lung cancer stage IV	PT
	18.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10066490	Progression of non-small cell lung cancer	LLT
	18.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10029521	Non-small cell lung cancer stage IIIB	PT
	18.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10059515	Non-small cell lung cancer metastatic	PT
	18.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10029515	Non-small cell lung cancer recurrent	PT
	18.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10061873	Non-small cell lung cancer	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed) FR (Ongoing) ES (Completed) GR (Completed) IT (Trial now transitioned)

Trial results: (No results available)

EudraCT Number: 2012-002392-33

Sponsor Protocol Number: N12HYB

Start Date*: 2012-06-12

Sponsor Name:NKI-AVL

Full Title: Phase I Hybrid study: combined stereotactic radiotherapy and conventional fractionation in stage II and III non small cell lung cancer with peripheral tumors smaller than 5 cm

Medical condition: NSCLC stage III or inoperable stage II

Disease:	Version	SOC Term	Classification Code	Term	Level
	14.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10062041	Lung infiltration malignant	PT
	14.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10023779	Large cell lung cancer stage III	PT
	14.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10025036	Lung adenocarcinoma stage II	PT
	14.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10062042	Lung neoplasm	PT
	14.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10029520	Non-small cell lung cancer stage IIIA	PT
	14.1	10038738 - Respiratory, thoracic and mediastinal disorders	10025082	Lung disorder	PT
	14.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10025031	Lung adenocarcinoma	PT
	14.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10029521	Non-small cell lung cancer stage IIIB	PT
	14.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10025069	Lung carcinoma cell type unspecified stage III	PT
	14.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10001250	Adenosquamous cell lung cancer stage II	PT
	14.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10025124	Lung squamous cell carcinoma stage III	PT
	14.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10025123	Lung squamous cell carcinoma stage II	PT
	14.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10061873	Non-small cell lung cancer	PT
	14.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10029518	Non-small cell lung cancer stage II	PT
	14.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10025037	Lung adenocarcinoma stage III	PT
	14.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10029519	Non-small cell lung cancer stage III	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: NL (Ongoing)

Trial results: (No results available)

EudraCT Number: 2018-003300-39

Sponsor Protocol Number: FCO-CYT-2018-01

Start Date*: 2018-12-21

Sponsor Name:Fundación para la Investigación Biomédica de Córdoba

Full Title: Clinical trial of efficacy and safety of the combination of reduced duration prophylaxis followed by immuno-guided prophylaxis in lung transplant recipients.

Medical condition: Cytomegalovirus Infection in subjects who underwent lung transplantation.

Disease:	Version	SOC Term	Classification Code	Term	Level
	20.1	10021881 - Infections and infestations	10011831	Cytomegalovirus infection	PT
	20.0	10022117 - Injury, poisoning and procedural complications	10010187	Complications of transplanted lung	PT
	20.0	10042613 - Surgical and medical procedures	10025127	Lung transplant	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: ES (Completed)

Trial results: (No results available)

EudraCT Number: 2013-000104-42

Sponsor Protocol Number: U31287-A-U201E

Start Date*: 2013-06-14

Sponsor Name:DAIICHI SANKYO DEVELOPMENT LTD.

Full Title: Open-label, Non-randomized Study of U3-1287 in Combination with Erlotinib in Subjects with Advanced Non-Small Cell Lung Cancer (NSCLC) - Extension

Medical condition: Treatment for advanced or metastatic NSCLC in combination with erlotinib in subjects who are epidermal growth factor receptor (EGFR) treatment naïve after failure of at least one prior chemotherapy...

Disease:	Version	SOC Term	Classification Code	Term	Level
	14.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10029522	Non-small cell lung cancer stage IV	PT
	14.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10029521	Non-small cell lung cancer stage IIIB	PT
	14.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10059515	Non-small cell lung cancer metastatic	PT

Population Age: Adults

Gender: Male, Female

Trial protocol: DE (Completed)

Trial results: View results

EudraCT Number: 2010-018614-70

Sponsor Protocol Number: D791AC00014

Start Date*: 2010-09-03

Sponsor Name:AstraZeneca AB

Full Title: An Open Label, Multicentre, Single Arm Study to Characterise the Efficacy, Safety and Tolerability of Gefitinib 250 mg (IRESSA™) as First line Treatment in Caucasian Patients, who have Epidermal Gr...

Medical condition: Non Small Cell Lung Cancer.

Disease:	Version	SOC Term	Classification Code	Term	Level
	12.1		10025053	Lung cancer non-small cell stage IIIA	LLT
	12.1		10025054	Lung cancer non-small cell stage IIIB	LLT
	12.1		10025055	Lung cancer non-small cell stage IV	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: PT (Completed) ES (Completed) GB (Completed) FR (Completed) IT (Completed) NO (Completed) HU (Completed) GR (Completed) BG (Completed)

Trial results: View results

EudraCT Number: 2019-002192-33

Sponsor Protocol Number: TRADEhypo

Start Date*: 2020-02-06

Sponsor Name:Frankfurter Institut für Klinische Krebsforschung IKF GmbH

Full Title: Thoracic Radiotherapy plus Durvalumab in Elderly and/or frail NSCLC stage III patients unfit for chemotherapy- Employing optimized (hypofractionated) radiotherapy to foster durvalumab efficacy

Medical condition: unresectable stage III NSCLC (Non–small-cell lung cancer)

Disease:	Version	SOC Term	Classification Code	Term	Level
	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10029519	Non-small cell lung cancer stage III	PT
	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10029520	Non-small cell lung cancer stage IIIA	PT
	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10029521	Non-small cell lung cancer stage IIIB	PT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10025052	Lung cancer non-small cell stage III	LLT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10025054	Lung cancer non-small cell stage IIIB	LLT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10025053	Lung cancer non-small cell stage IIIA	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Trial now transitioned)

Trial results: (No results available)

EudraCT Number: 2011-000711-85

Sponsor Protocol Number: MEF4984g

Start Date*: 2011-10-17

Sponsor Name:Genentech, Inc

Full Title: A PHASE II, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY EVALUATING THE SAFETY AND EFFICACY OF MEGF0444A IN COMBINATION WITH CARBOPLATIN, PACLITAXEL AND BEVACIZUMAB IN PATIENTS ...

Medical condition: ADVANCED OR RECURRENT NON-SQUAMOUS NON-SMALL CELL LUNG CANCER WHO HAVE NOT RECEIVED PRIOR CHEMOTHERAPY FOR ADVANCED DISEASE

Disease:	Version	SOC Term	Classification Code	Term	Level
	14.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10025054	Lung cancer non-small cell stage IIIB	LLT
	14.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10025052	Lung cancer non-small cell stage III	LLT
	14.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10025048	Lung cancer non-small cell recurrent	LLT
	14.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10025051	Lung cancer non-small cell stage II	LLT
	14.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10025046	Lung cancer cell type unspecified stage IV	LLT
	14.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10025055	Lung cancer non-small cell stage IV	LLT
	14.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10025053	Lung cancer non-small cell stage IIIA	LLT
	14.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10025050	Lung cancer non-small cell stage I	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: CZ (Prematurely Ended) HU (Prematurely Ended)

Trial results: View results

EudraCT Number: 2021-006454-30

Sponsor Protocol Number: 23537

Start Date*: 2023-02-09

Sponsor Name:DIPARTIMENTO DI SCIENZE CHIRURGICHE - UNIVERSITà DEGLI STUDI DI TORINO

Full Title: Near-infrared molecular imaging for lung cancer detection and treatment during mini-invasive surgery (Phase II Trial)

Medical condition: To date, lung resection and lymphadenectomy remains the best curative option in patients with early-stage non-small cell lung cancer. Moreover, cancer screening programs have led to a frequent diag...

Disease:	Version	SOC Term	Classification Code	Term	Level
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10062042	Lung neoplasm	PT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10062042	Lung neoplasm	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: IT (Completed)

Trial results: (No results available)

EudraCT Number: 2013-000139-28

Sponsor Protocol Number: 12_DOG07_146

Start Date*: 2013-03-22

Sponsor Name:The Christie NHS Foundation Trust

Full Title: A single arm double-blind placebo controlled cross-over trial of Aprepitant for the treatment of cough in lung cancer: “CALC” Trial

Medical condition: Cough relating to lung cancer

Disease:	Version	SOC Term	Classification Code	Term	Level
	15.1	100000004864	10025044	Lung cancer	LLT
	15.1	10038738 - Respiratory, thoracic and mediastinal disorders	10011224	Cough	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GB (Completed)

Trial results: View results

EudraCT Number: 2010-024468-16

Sponsor Protocol Number: BO25460

Start Date*: 2011-06-29

Sponsor Name:F. Hoffmann-La Roche Ltd

Full Title: A randomized, double-blind, placebo-controlled Phase III study of first-line maintenance Tarceva vs Tarceva at the time of disease progression in patients with advanced non-small cell lung cancer (...

Medical condition: Advanced (Stage IIIB or IV) NSCLC previously treated with 4 cycles of a platinum-based chemotherapy (for Traceva®).

Disease:	Version	SOC Term	Classification Code	Term	Level
	14.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10029522	Non-small cell lung cancer stage IV	PT
	14.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10029521	Non-small cell lung cancer stage IIIB	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: SK (Completed) HU (Completed) CZ (Completed) LV (Completed) LT (Completed) NL (Completed) FR (Completed) BG (Completed) IT (Completed)

Trial results: View results

EudraCT Number: 2014-001436-10

Sponsor Protocol Number: INCB18424-266

Start Date*: 2015-02-26

Sponsor Name:Incyte Corporation

Full Title: A Randomized, Double-Blind Phase 2 Study of Ruxolitinib or Placebo in Combination With Pemetrexed/Cisplatin and Pemetrexed Maintenance for Initial Treatment of Subjects With Nonsquamous Non–Small C...

Medical condition: Nonsquamous NSCLC that is Stage IIIB, Stage IV, or recurrent

Disease:	Version	SOC Term	Classification Code	Term	Level
	17.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10029522	Non-small cell lung cancer stage IV	PT
	17.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10029521	Non-small cell lung cancer stage IIIB	PT
	17.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10059515	Non-small cell lung cancer metastatic	PT
	17.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10061873	Non-small cell lung cancer	PT
	17.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10029515	Non-small cell lung cancer recurrent	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: IT (Completed) DK (Prematurely Ended) ES (Prematurely Ended) NL (Completed) PT (Completed)

Trial results: View results

EudraCT Number: 2015-003715-38

Sponsor Protocol Number: D4190C00006

Start Date*: 2016-05-12

Sponsor Name:MedImmune LLC

Full Title: A Phase 1b Open-label Study to Evaluate the Safety and Tolerability of MEDI4736 in Combination with Tremelimumab in Subjects with Advanced Non-small Cell Lung Cancer

Medical condition: Locally advanced or metastatic squamous or nonsquamous non- small cell lung cancer (NSCLC)

Disease:	Version	SOC Term	Classification Code	Term	Level
	20.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10029520	Non-small cell lung cancer stage IIIA	PT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10029522	Non-small cell lung cancer stage IV	PT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10029521	Non-small cell lung cancer stage IIIB	PT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10066490	Progression of non-small cell lung cancer	LLT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10059515	Non-small cell lung cancer metastatic	PT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10061873	Non-small cell lung cancer	PT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10029519	Non-small cell lung cancer stage III	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: BE (Completed) ES (Completed) DE (Completed) GB (Completed) FR (Completed)

Trial results: View results

Subscribe to this Search
To subscribe to the RSS feed for this search click here

. This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.

Download Options:
Number of Trials to download:

Download Content:

Download Format:


Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.

Query did not match any studies.

Select Country:	Select Age Range:
Select Trial Status:	Select Trial Phase:
Select Gender:
Select Date Range: to
Select Rare Disease:
IMP with orphan designation in the indication
Orphan Designation Number:
Results Status:
Clear advanced search filters

Austria
Belgium
Bulgaria
Croatia
Cyprus
Czechia
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Iceland
Ireland
Italy
Latvia
Liechtenstein
Lithuania
Luxembourg
Malta
Netherlands
Norway
Poland
Portugal
Romania
Slovakia
Slovenia
Spain
Sweden
United Kingdom
Outside EU/EEA

Clinical trials for Lung diseases